Filing Details

Accession Number:
0001144204-11-033623
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-06-01 21:12:43
Reporting Period:
2011-05-25
Filing Date:
2011-06-01
Accepted Time:
2011-06-01 21:12:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326190 Pharmathene Inc PIP Pharmaceutical Preparations (2834) 202726770
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1409487 D Valerie Riddle C/O Pharmathene, Inc.
One Park Place, Suite 450
Annapolis MD 21401
Svp, Medical Director No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.0001 Par Value Per Share Acquisiton 2011-05-25 4,775 $2.96 54,565 No 4 M Direct
Common Stock, $0.0001 Par Value Per Share Disposition 2011-05-25 4,775 $3.75 49,790 No 4 S Direct
Common Stock, $0.0001 Par Value Per Share Acquisiton 2011-05-31 3,438 $2.46 53,228 No 4 M Direct
Common Stock, $0.0001 Par Value Per Share Disposition 2011-05-31 3,438 $4.00 49,790 No 4 S Direct
Common Stock, $0.0001 Par Value Per Share Disposition 2011-05-31 5,354 $4.01 44,436 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to purchase Disposition 2011-05-25 4,775 $0.00 4,775 $2.96
Common Stock Option to purchase Disposition 2011-05-31 3,438 $0.00 3,438 $2.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
14,317 2013-10-14 No 4 M Direct
20,627 2019-01-21 No 4 M Direct
Footnotes
  1. The transactions reported hereon have been effected pursuant to the Reporting Person's 10b5-1 Plan.
  2. The option exercised is part of a October 14, 2003 grant of options to purchase an aggregate of 19,092 shares, which is fully vested.
  3. The option exercised is part of a January 21, 2009 grant of options to purchase an aggregate of 27,503 shares, which vests over a 4 year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant date.